What it does
Dienosis is a medication used to treat specific health conditions, though details about its drug class, interactions, and cautions are not provided.
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.
Sourcing - Kenya onlyRegistration & product details
Source: Food and Drugs Authority · fetched 2026-04-18 08:32:58 · updated 2026-09-18 04:00:07
About this medicine
Dienosis is a medication used to treat specific health conditions, though details about its drug class, interactions, and cautions are not provided.
How it works
The exact mechanism of how dienosis works is not detailed, but it is intended to help manage certain medical conditions.
Who it's for
Dienosis is prescribed for individuals with specific health issues, but the exact conditions are not listed.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: dienosis
Dienogest is a synthetic progestin, a derivative of 19-norsteroid, primarily used in hormonal contraceptives and for the treatment of endometriosis. It mimics the effects of natural progesterone, helping to regulate menstrual cycles and manage hormonal changes in the body.
Indications
- Hormonal contraception
- Management of endometriosis
- Dysmenorrhea
- Menstrual irregularities
Dosage
Children: Refer to the BNF for Children for specific dosing recommendations.
Adults: Refer to specific product guidelines for dosing. It is typically administered once daily.
Mechanism of action
Dienogest works by binding to progesterone receptors, leading to alterations in gene expression that inhibit ovulation, reduce endometrial proliferation, and induce secretory changes in the endometrium. It also affects the hypothalamic-pituitary-gonadal axis, leading to decreased secretion of gonadotropins, which further prevents ovarian follicle development.
Pharmacodynamics
Dienogest has anti-inflammatory properties and can reduce the growth of endometrial tissue outside the uterus. It also alters the cervical mucus to create a barrier for sperm, thereby preventing fertilization. The drug exhibits a favorable profile with minimal androgenic effects compared to other progestins, which is beneficial for patients with hormonal sensitivity.
Pharmacokinetics
Dienogest is well absorbed after oral administration, with peak plasma concentrations occurring approximately 1 to 2 hours post-dose. It has a half-life of about 9 to 10 hours, allowing for once-daily dosing in most formulations. The drug is metabolized primarily in the liver via cytochrome P450 enzymes, and its metabolites are excreted primarily in urine. The bioavailability is affected by food, with higher absorption when taken with meals.
Pregnancy
Information on the use of dienosis during pregnancy is limited. Consult a healthcare provider for guidance.
Breast-feeding
Dienosis may pass into breast milk. Caution is advised when administering to nursing mothers.
Storage
Store at room temperature, away from moisture and heat. Keep out of reach of children.
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.